Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors
October 04, 2023 10:08 ET
|
Lowey Dannenberg, P.C.
NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating a potential breach of fiduciary duty claim...
Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors
September 29, 2023 14:45 ET
|
Lowey Dannenberg, P.C.
NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating a potential breach of fiduciary duty...
Pharmacogenomics Market is estimated to be US$ 33.10 million by 2030 with a CAGR of 4.50% during the forecast period - By PMI
March 14, 2023 08:35 ET
|
PMI
Covina, March 14, 2023 (GLOBE NEWSWIRE) -- Pharmacogenomics Market accounted for US$ 6753.66 million in 2020 and is estimated to be US$ 15796.9 million by 2030 and is anticipated to register a CAGR...
Solid Tumor Testing Market to Grow $46.7 Billion by 2031: Allied Market Research
November 09, 2022 02:43 ET
|
Allied Market Research
Portland, OR, Nov. 09, 2022 (GLOBE NEWSWIRE) -- A new business intelligence report released by Allied Market Research, the global Solid Tumor Testing Market garnered $23.8 billion in 2021, and is...
Global Lung Cancer Diagnostic Test Market is estimated to be US$ 4.07 billion by 2030 with a CAGR of 7.50% during the forecast period - By PMI
April 19, 2022 09:52 ET
|
PMI
Covina, April 19, 2022 (GLOBE NEWSWIRE) -- Lung cancer starts in the lungs and can spread to the lymph nodes or other body organs, including the brain. Cancer that has progressed to other organs can...
Global Bioinformatics Platform Market is estimated to be US$ 14.0 Billion by 2029 with a CAGR of 14.7% during the Forecast Period - PMI
June 15, 2020 11:35 ET
|
PMI
Covina, CA, June 15, 2020 (GLOBE NEWSWIRE) -- The global bioinformatics platform market accounted for US$ 3.6 billion in 2019 and is estimated to be US$ 14.0 billion by 2029 and is anticipated to...
Burning Rock deepens cooperation with Illumina to promote development and standardization of NGS-based cancer therapy selection in China
May 10, 2020 20:00 ET
|
Burning Rock Biotech Limited
SHANGHAI, China, May 10, 2020 (GLOBE NEWSWIRE) -- Burning Rock and Illumina (NASDAQ: ILMN), a global leader in gene sequencing and array-based technologies, jointly announced today that they are...
Update: Lawsuit for Investors in NASDAQ: ILMN shares against Illumina, Inc. announced by Shareholders Foundation
June 12, 2018 09:10 ET
|
Shareholders Foundation, Inc.
SAN DIEGO, June 12, 2018 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Illumina, Inc. (NASDAQ:ILMN). Investors, who...
Harvard Pilgrim and Illumina sign first-of-its-kind value-based contract
February 20, 2018 10:00 ET
|
Real Endpoints
SAN DIEGO, WELLESLEY, Mass. and WESTPORT, Conn., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Illumina, Inc. and Harvard Pilgrim Health Care announced on February 1 a major new value-based contract (VBC) – one...
ILMN LOSS ALERT: Rosen Law Firm Reminds Illumina, Inc. Investors of Important Deadline in Class Action – ILMN
January 24, 2017 20:35 ET
|
The Rosen Law Firm PA
NEW YORK, Jan. 24, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Illumina, Inc. securities (NASDAQ:ILMN) from July 26, 2016 through October 10,...